search
Back to results

OptiBra Study, Optimal Postoperative Bra After Breastcancer Surgery

Primary Purpose

Bra, Breast Cancer Surgery, Complication

Status
Unknown status
Phase
Phase 3
Locations
Sweden
Study Type
Interventional
Intervention
OptiBra study
Sponsored by
Karolinska University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Bra

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

Women from 18 years

Malignant tumor of the breast gland to undergo surgery.

Exclusion Criteria:

Men with breast cancer Women with benign tumors Women with health factors where the assessment is that BRA use is not necessary or possible.

Sites / Locations

  • Karolinska University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

standard

compression bra

Arm Description

Standard bra, soft

experimental bra, compression and stabile

Outcomes

Primary Outcome Measures

Pain intensity measure
VAS scale ( Visual analoge scale) , each item is score, 0= no pain to 10= pain as bad as can be. yielding at total between 0 and 10

Secondary Outcome Measures

Postoperative breastsymptoms
Clinical observation by doktor 3 weeks after surgery and Medical records
Seroma
Clinical observation by doktor registrated in Medical journal about number of dropping and ml each dropping. And % of patients suffering from seroma after surgery
Patients experience of symptoms and comfort
EORTC QLQ BR23 questionnaire measure symptoms after breascancer surgery, a 4 item scale, each item i scored from -not at all to verry mutch. We will follow the EORTC QLQ manual for calculation, scale 1-100, where high scores mean more severe symptoms And some study specific questions about experience of Comfort ex.have you experienced that the BRA has given you support
Pain medication intake after surgery
Self care-diary

Full Information

First Posted
July 26, 2019
Last Updated
August 15, 2019
Sponsor
Karolinska University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04059835
Brief Title
OptiBra Study, Optimal Postoperative Bra After Breastcancer Surgery
Official Title
OptiBra Study, Optimal Postoperative Bra After Breastcancer Surgery - an RCT
Study Type
Interventional

2. Study Status

Record Verification Date
August 2019
Overall Recruitment Status
Unknown status
Study Start Date
May 20, 2019 (Actual)
Primary Completion Date
May 30, 2020 (Anticipated)
Study Completion Date
May 30, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluates how two different types of postoperative bra 1) standard bra, soft VS 2) compression bra compression after breast cancer surgery affect pain, seroma, other symptoms and complications, and the womans experience of comfort
Detailed Description
Background Breast cancer is the most common form of cancer in women and in Sweden about 9700 women are affected each year.Therefore, it is of great importance to promote the rehabilitation process by minimizing unnecessary symptoms and complications that may arise during a breast cancer treatment. Surgery is the primary cure for breast cancer and about 40% need to undergo a major surgical procedur and major operations also involve an increased risk of complications and symptoms. Pain is the most common reported symptom in women who are operated on for breast cancer other complications after surgery that may occur are seroma, wound infektions and swelling. No published evidence exists for the benefit and effect in pain relief from wearing a bra as a support after breast surgery is available, therefore it is important to evaluate useful and simple methods that the patient can manage herself that can minimize the experience of pain and other symptom after breast cancer surgery. At Karolinska University Hospital's breast cancer center, women who undergo breast surgery are offered a bra after surgery in order to provide good support for the patient to feel safe, comfortable and minimize complications and symptoms such as pain. Two different types of bra are used and, according to the clinical staff at Karolinska's breast cancer center clinical experience, there is disagreement about which type of bra gives the optimal effect in different surgical procedures to reduce symptoms and post-operative complications. Neither is there enough knowledge about and how women experience comfort from the bra they received from the healthcare, which is important as the bra should be used large parts of the day for about 3 weeks after the procedure. Lack of knowledge makes it difficult to provide person-centered care for each individual. The purpose of this study is to compare two different types of bra after breast cancer surgery and to evaluate whether a particular type of bra affects the perception of pain, other symptoms, the occurrence of complications and experiences of bra comfort. Purpose To compare two different types of postoperative-bra after breast cancer surgery and to evaluate how a particular type of bra affects the perception of pain, other symptoms, the occurrence of complications and comfort. Outcome Measure The primary outcome measure is the presence of pain. Secondary outcome measures are, other symptoms, seroma, wound complications, and the patient's experience of satisfaction with support and comfort when using their postoperative bra. Design Randomized controlled trial aimed to comparing two groups of women undergoing breast cancer surgery. Participant Women diagnosed with breast cancer and undergoing breast surgery. Data Collection The data collection will take place at the Breast Center, Karolinska University Hospital in Solna, where approximately 500 breast cancer operations are performed every year. The women will be identified by the nurse or doctor at the MDT conference. The identified women will be asked about the participation of the nurse / doctor at the new visit to the surgeon's reception and bring written information home with them about the study. A few days after the new visit, the woman is called by a researcher or nurse for further oral information and the women who wish to participate will be given written informed consent. After this, baseline measurement and randomization are performed to one of two groups. Evaluation will be performed on two occasions, prior to surgery (baseline for pain and other symptoms, demographic issues) and 3 weeks after surgery (pain, symptoms, clinical assessment of the breast). Demographic (age, education, etc.) and medical information (weight, BMI, illness history, smoking, alcohol habits and physical activity, etc.) as well as the type of surgical procedure and drain are collected through medical records. Inclusion Women from 18 years of age with malignant tumor of the breast gland to undergo surgery. Exclusion Men with breast cancer. Women with benign tumors or women with health factors where the assessment is that Bra use from healthcare is not necessary or possible. Compliance and instruments The participant will be instructed to use the bra according to. Instruction and adherence to intervention will be via diary pages where the participant for 3 weeks briefly fills in (number of days) and how often (number of hours / day) you have used the bra you received from the health care. Primary outcome measure is; pain, secondary outcome measures are, presence of seroma, symptoms after breast surgery mainly swelling, redness, and satisfaction with the use of bra focusing on comfort and support. Instruments for self-estimated outcome measures that will be used are; To measure the perception of pain comes the estimation instrument VAS (visual analogue scale). VAS is a 10 cm long horizontal line where on one side measures "no pain" and on the other "worst possible pain" and the patient places a mark on the line corresponding to the perceived pain . To measure chest symptoms, EORCT QLQ-BR 23 will be used. BR 23 is a questionnaire that measures common symptoms of breast cancer disease and treatment (eg you have had difficulty lifting or moving your arm, have you had pain around your breast). The presence of wound complications, seroma and other symptoms reported by the patient (swelling, redness) will be assessed by clinical assessment of the nurse and medical record. E.g. Seroma will be assessed on the basis of a template based on the number of drops and the amount / ml of dropped liquid. To examine how participants experience the convenience, comfort, and support of the postoperative bra they used in the study, participants will answer study-specific questions (open and closed) regarding patient experience (patient satisfaction) regarding BRA use that relates to comfort, support and comfort. Intervention Participants are randomized into one of two groups. Group 1) is offered the more stable bra with some compression after breast cancer surgery, while Group 2) is offered a softer bra without compression. Participants are encouraged to use the bra according to instructions and record the number of hours / days for use in a diary. When returning to a nurse / doctor after about 3 weeks of use, all participants respond to survey questions about pain, other symptoms and experience of support and comfort during use, and undergo a clinical assessment of the nurse according to a template with respect to seroma, number of taps, quantity and occurrence of complications (eg wound infection). Compliance with intervention takes place trough a simple diary which participants fill in for 3 weeks eg. how long (number of days) and often (number of hours / day) have you used the bra you received from the healthcare system, as well as grading daily pain according to the VAS- scale. To determine if there are differences between 2 groups with respect to the variable pain as the primary outcome measure, a sample size of 80 women per group is calculated to be necessary with a power of 0.80 percent and a significance level of <0.05. Given that subgroup analyzes (about 5 groups - mastectomy +- SN, mastectomy +- axillary, sector + - SN, sector +- axillary and primary reconstruction) will be done and a planned 10% drop-out, 100 women per group will be included. Analysis Quantitative data will be processed using relevant statistical parametric methods for normally distributed data and non-parametric methods for non-normally distributed data. Analyzes will investigate differences between groups as well as within the group (ANOVA) as well as analyzes for the relationship between different parameters (eg type of bra and surgical procedure). Demographic baseline data is reported as descriptive statistics (SD, mean, frequency). Statistics will be used for support. Ethical issues The current research project will follow the basic ethical principles that include the information requirement, the consent requirement, the confidentiality requirement and the use requirement . Involved persons in the team for the BH study all have long experience of meeting people with cancer diagnosis. Close ethical discussion with expertise in the research group on the routines that exist today for bra use after surgery and in randomization so as not to cause or risk injury to the woman. All participants will; receive oral and written information about the study, have the opportunity to ask questions via telephone or mail during the entire study period (the information requirement). Participants will be informed that participation is completely voluntary and that there is no disadvantage if participation is canceled (the consent requirement). Personal data will be de-identified and handled in accordance with statutes to minimize the identity of the participants for unauthorized persons in the reporting of results (the confidentiality requirement). The collected data will only be used for research purposes (the use requirement).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bra, Breast Cancer Surgery, Complication, Compression, Symptoms

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Factorial Assignment
Model Description
Randomized controlled trial two Groups
Masking
None (Open Label)
Masking Description
Not blinded but randomized
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
standard
Arm Type
Active Comparator
Arm Description
Standard bra, soft
Arm Title
compression bra
Arm Type
Experimental
Arm Description
experimental bra, compression and stabile
Intervention Type
Other
Intervention Name(s)
OptiBra study
Intervention Description
compare two different bra after breast cancer surgery
Primary Outcome Measure Information:
Title
Pain intensity measure
Description
VAS scale ( Visual analoge scale) , each item is score, 0= no pain to 10= pain as bad as can be. yielding at total between 0 and 10
Time Frame
21 days from operations day
Secondary Outcome Measure Information:
Title
Postoperative breastsymptoms
Description
Clinical observation by doktor 3 weeks after surgery and Medical records
Time Frame
report every day, 21 days after operation
Title
Seroma
Description
Clinical observation by doktor registrated in Medical journal about number of dropping and ml each dropping. And % of patients suffering from seroma after surgery
Time Frame
This will be examine 21 days after the surgery at the revisit to surgon
Title
Patients experience of symptoms and comfort
Description
EORTC QLQ BR23 questionnaire measure symptoms after breascancer surgery, a 4 item scale, each item i scored from -not at all to verry mutch. We will follow the EORTC QLQ manual for calculation, scale 1-100, where high scores mean more severe symptoms And some study specific questions about experience of Comfort ex.have you experienced that the BRA has given you support
Time Frame
Reported basline and 21 days after operation
Title
Pain medication intake after surgery
Description
Self care-diary
Time Frame
Report every day, 21 days after operation

10. Eligibility

Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Women from 18 years Malignant tumor of the breast gland to undergo surgery. Exclusion Criteria: Men with breast cancer Women with benign tumors Women with health factors where the assessment is that BRA use is not necessary or possible.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Backman
Phone
+46739167393
Email
malin.backman@sll.se
First Name & Middle Initial & Last Name or Official Title & Degree
Fredriksson
Phone
+46739808830
Email
irma.fredriksson@sll.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Malin Backman
Organizational Affiliation
Karolinska University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Karolinska University Hospital
City
Stockholm
ZIP/Postal Code
46
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Backman
Phone
+46739167393
Email
malin.backman@sll.se
First Name & Middle Initial & Last Name & Degree
Fredriksson
Email
irma.fredriksson@sll.se

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
Citation
Fallbjörk U, Salander P & Rasmussen BH. From
Results Reference
result

Learn more about this trial

OptiBra Study, Optimal Postoperative Bra After Breastcancer Surgery

We'll reach out to this number within 24 hrs